Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- PMID: 16868999
- DOI: 10.1002/art.21978
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
Abstract
Objective: To determine whether the rate of serious infection is higher in anti-tumor necrosis factor (anti-TNF)-treated rheumatoid arthritis (RA) patients compared with RA patients treated with traditional disease-modifying antirheumatic drugs (DMARDs).
Methods: This was a national prospective observational study of 7,664 anti-TNF-treated and 1,354 DMARD-treated patients with severe RA from the British Society for Rheumatology Biologics Register. All serious infections, stratified by site and organism, were included in the analysis.
Results: Between December 2001 and September 2005, there were 525 serious infections in the anti-TNF-treated cohort and 56 in the comparison cohort (9,868 and 1,352 person-years of followup, respectively). The incidence rate ratio (IRR), adjusted for baseline risk, for the anti-TNF-treated cohort compared with the comparison cohort was 1.03 (95% confidence interval 0.68-1.57). However, the frequency of serious skin and soft tissue infections was increased in anti-TNF-treated patients, with an adjusted IRR of 4.28 (95% confidence interval 1.06-17.17). There was no difference in infection risk between the 3 main anti-TNF drugs. Nineteen serious bacterial intracellular infections occurred, exclusively in patients in the anti-TNF-treated cohort.
Conclusion: In patients with active RA, anti-TNF therapy was not associated with increased risk of overall serious infection compared with DMARD treatment, after adjustment for baseline risk. In contrast, the rate of serious skin and soft tissue infections was increased, suggesting an important physiologic role of TNF in host defense in the skin and soft tissues beyond that in other tissues.
Similar articles
-
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146. JAMA. 2009. PMID: 19224750
-
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.Ann Rheum Dis. 2009 Feb;68(2):209-15. doi: 10.1136/ard.2007.087288. Epub 2008 Apr 2. Ann Rheum Dis. 2009. PMID: 18385277 Free PMC article.
-
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.J Rheumatol. 2011 Jul;38(7):1258-64. doi: 10.3899/jrheum.101009. Epub 2011 Apr 15. J Rheumatol. 2011. PMID: 21498482
-
[New drugs and treatment strategies for rheumatoid arthritis].Recenti Prog Med. 2003 Sep;94(9):361-79. Recenti Prog Med. 2003. PMID: 12942798 Review. Italian.
-
Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.Mod Rheumatol. 2007;17(6):451-8. doi: 10.1007/s10165-007-0626-3. Epub 2007 Dec 20. Mod Rheumatol. 2007. PMID: 18084695 Review.
Cited by
-
A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK.BMC Musculoskelet Disord. 2016 Aug 4;17:322. doi: 10.1186/s12891-016-1187-4. BMC Musculoskelet Disord. 2016. PMID: 27491386 Free PMC article.
-
Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: case series and literature review.Can J Gastroenterol. 2009 Dec;23(12):829-33. doi: 10.1155/2009/836938. Can J Gastroenterol. 2009. PMID: 20011736 Free PMC article.
-
Outcomes following total elbow arthroplasty for rheumatoid arthritis versus post-traumatic conditions: a systematic review and meta-analysis.Bone Joint J. 2019 Dec;101-B(12):1489-1497. doi: 10.1302/0301-620X.101B12.BJJ-2019-0799.R1. Bone Joint J. 2019. PMID: 31786989 Free PMC article.
-
Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures.Acta Orthop. 2013 Oct;84(5):495-501. doi: 10.3109/17453674.2013.842431. Epub 2013 Sep 16. Acta Orthop. 2013. PMID: 24032521 Free PMC article.
-
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label.Arthritis Res Ther. 2011 Jul 11;13(4):R112. doi: 10.1186/ar3397. Arthritis Res Ther. 2011. PMID: 21745378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical